Vancouver, British Columbia, March 8, 2017 – Precision NanoSystems has launched the NanoAssemblr™ Scale-Up system to support the clinical development of nanomedicines. This latest addition
Argonaut Manufacturing Services, a contract manufacturing organization (CMO) dedicated to serving the life science and molecular diagnostics markets, announced today that it has received ISO
AUSTIN, Texas − February 20, 2017 − Asuragen, Inc., a global molecular diagnostics company, announced today that it has entered into a collaboration agreement with Thermo
SAN DIEGO, Calif., February 9, 2017 – Agena Bioscience today announced a comparative study published in Scientific Reports highlighting the use of its mass spec-based
GUILFORD, CT, JANUARY 31, 2017 University of Florida Health Shands Hospital (UF Health Shands) has selected Medpricer Analytics™ to gain additional visibility into their Purchased
CARDIFF, WALES, UK – TrakCel, the leading provider of cellular orchestration technology to aid in the delivery of regenerative therapies, has successfully completed a multi-million
Precision NanoSystems, Inc. (PNI), a global nanomedicine company, has announced the completion of a $13.4 million private Series A financing. The investment was led by
FREMONT, Calif.– (BUSINESS WIRE)–Nitinol Devices & Components, Inc. (“NDC”), announced today it has successfully completed the acquisition of Interface Catheter Solutions (“Interface”). Reflecting the combination’s
Mountain View, CA—December 4, 2014—/PRNewswire/—PneumRx, Inc. (www.pneumrx.com), a leader in the field of interventional pulmonology, today announced that it has signed an agreement to be
Acquisition makes Horizon the world’s leading gene-editing and translational genomics company Highlights Horizon acquires Sage Labs Inc. for up to $48M (£29M) comprising up to
Colorado Springs, Colo., June 30, 2014 (GLOBE NEWSWIRE)—The Spectranetics Corporation (Nasdaq:SPNC) today announced that it has completed the acquisition of AngioScore Inc., a leading developer,
John Lillig to Lead Agena Bioscience as Chairman and Interim CEO San Diego, Calif., May 30, 2014—Agena Bioscience, Inc., a portfolio company of Telegraph Hill
This website uses cookies and similar technologies to support basic site functionality and help us understand how visitors use the site. We use analytics tools such as Google Analytics, to improve website performance and content.We do not sell personal information or use cookies for targeted advertising.You can accept all cookies, reject non-essential cookies, or adjust your preferences at any time. For more information, please review our Privacy Policy.
Essential cookies and services enable basic functions and are necessary for the proper functioning of the website.
This category includes all cookies, domains, and services that do not fall into the other specified categories or have not been explicitly categorized.
This website uses cookies to enhance your browsing experience and ensure the site functions properly. By continuing to use this site, you acknowledge and accept our use of cookies.
